[1]
“Clinical experience of the use of Vasavital® in dry age-related macular degeneration and ischemic optic neuropathy”, Ukr. j. ophthalmol. , no. 1, pp. 38–45, Sep. 2025, doi: 10.31288/oftalmolzh202113845.